...Caucasian or African-American have been sequenced. In the near term, the new information is expected to revolutionize drug development, making it much easier for pharmaceutical companies to target their products at the actual causes of disease. Today...

...discoveries can be exploited and controlled. Pharmaceutical companies view bioprospecting as an alternative for drug development to their traditional, chemistry-based manufacturing process. Other companies are looking to nature for industrial...

...defense to fend off possible hostile takeover attempts. Long-term investors in Geron are apt to be hurt -- and drug development delayed -- if President Bush orders a permanent ban on federal funding for embryonic stem cell research. With or...